CellCept (Mycophenolate)

mycophenolate mofetil 1 g/5 mL powder for oral liquid, 165 mL · ORAL · PBS code 6364Y

STREAMLINED

What it costs

AU$186.1 PBS-determined price per 2 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2003-02-01.
• Repeats: 5.
• PBS program: HS.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Management of renal allograft rejection

Management (initiation, stabilisation and review of therapy)

Patient must be receiving this drug for prophylaxis of renal allograft rejection; AND

The treatment must be under the supervision and direction of a transplant unit.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Management of cardiac allograft rejection

Management (initiation, stabilisation and review of therapy)

Patient must be receiving this drug for prophylaxis of cardiac allograft rejection; AND

The treatment must be under the supervision and direction of a transplant unit.

Sponsor: Roche Products Pty Ltd ABN 70 000 132 865

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.